| Report Title | Price | Action |
|---|---|---|
| Oropharyngeal Candidiasis (Infectious Disease) - Drugs in Development, 2021
Oropharyngeal Candidiasis (Infectious Disease) - Drugs in Development, 2021 Summary Oropharyngeal Candidiasis (Infectious Disease) - Drugs in Develo...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Bone Degeneration (Musculoskeletal) - Drugs in Development, 2021
Bone Degeneration (Musculoskeletal) - Drugs in Development, 2021 Summary Bone Degeneration (Musculoskeletal) - Drugs in Development, 2021 provides a...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Mucosa Associated Lymphoid Tissue Lymphoma Translocation Protein 1 (MALT Lymphoma Associated Translocation or Paracaspase or MALT1 or EC 3.4.22.) - Drugs in Development, 2021
Mucosa Associated Lymphoid Tissue Lymphoma Translocation Protein 1 (MALT Lymphoma Associated Translocation or Paracaspase or MALT1 or EC 3.4.22.) - Dr...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Voltage Dependent T Type Calcium Channel - Drugs in Development, 2021
Voltage Dependent T Type Calcium Channel - Drugs in Development, 2021 Summary Voltage Dependent T Type Calcium Channel - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Cells Expressing Vascular Endothelial Growth Factor Receptor 2 (Fetal Liver Kinase 1 or Kinase Insert Domain Receptor or Protein Tyrosine Kinase Receptor flk 1 or VEGFR2 or CD309 or KDR or EC 2.7.10.1) - Drugs in Development, 2021
Cells Expressing Vascular Endothelial Growth Factor Receptor 2 (Fetal Liver Kinase 1 or Kinase Insert Domain Receptor or Protein Tyrosine Kinase Recep...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021
Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021 Summary Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Generalized Anxiety Disorder (GAD) (Central Nervous System) - Drugs in Development, 2021
Generalized Anxiety Disorder (GAD) (Central Nervous System) - Drugs in Development, 2021 Summary Generalized Anxiety Disorder (GAD) (Central Nervous...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Pancreatic Ductal Adenocarcinoma (Oncology) - Drugs in Development, 2021
Pancreatic Ductal Adenocarcinoma (Oncology) - Drugs in Development, 2021 Summary Pancreatic Ductal Adenocarcinoma (Oncology) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 325
|
$ 2500 | |
| Bone Fracture (Musculoskeletal) - Drugs in Development, 2021
Bone Fracture (Musculoskeletal) - Drugs in Development, 2021 Summary Bone Fracture (Musculoskeletal) - Drugs in Development, 2021 provides an overvi...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 | |
| NKG2 D Type II Integral Membrane Protein (Killer Cell Lectin Like Receptor Subfamily K Member 1 or NK Cell Receptor D or NKG2 D Activating NK Receptor or CD314 or KLRK1) - Drugs in Development, 2021
NKG2 D Type II Integral Membrane Protein (Killer Cell Lectin Like Receptor Subfamily K Member 1 or NK Cell Receptor D or NKG2 D Activating NK Receptor...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Von Willebrand Factor (VWF) - Drugs in Development, 2021
Von Willebrand Factor (VWF) - Drugs in Development, 2021 Summary Von Willebrand Factor (VWF) - Drugs in Development, 2021 provides in depth analysis...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Complement C1q Subcomponent - Drugs in Development, 2021
Complement C1q Subcomponent - Drugs in Development, 2021 Summary Complement C1q Subcomponent - Drugs in Development, 2021 provides in depth analysis...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Mycobacterium Infections (Infectious Disease) - Drugs in Development, 2021
Mycobacterium Infections (Infectious Disease) - Drugs in Development, 2021 Summary Mycobacterium Infections (Infectious Disease) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Post Operative Nausea And Vomiting (Gastrointestinal) - Drugs in Development, 2021
Post Operative Nausea And Vomiting (Gastrointestinal) - Drugs in Development, 2021 Summary Post Operative Nausea And Vomiting (Gastrointestinal) - D...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Pancreatic Endocrine Tumor (Oncology) - Drugs in Development, 2021
Pancreatic Endocrine Tumor (Oncology) - Drugs in Development, 2021 Summary Pancreatic Endocrine Tumor (Oncology) - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Bone Regeneration (Musculoskeletal) - Drugs in Development, 2021
Bone Regeneration (Musculoskeletal) - Drugs in Development, 2021 Summary Bone Regeneration (Musculoskeletal) - Drugs in Development, 2021 provides a...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| P2Y Purinoceptor 12 (ADP Glucose Receptor or P2Y12 Platelet ADP Receptor or SP1999 or P2T(AC) or P2Y(AC) or P2Y(cyc) or P2Y12 or P2RY12) - Drugs in Development, 2021
P2Y Purinoceptor 12 (ADP Glucose Receptor or P2Y12 Platelet ADP Receptor or SP1999 or P2T(AC) or P2Y(AC) or P2Y(cyc) or P2Y12 or P2RY12) - Drugs in De...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Calcium Release Activated Calcium Channel Protein 1 (Protein Orai 1 or Transmembrane Protein 142A or ORAI1) - Drugs in Development, 2021
Calcium Release Activated Calcium Channel Protein 1 (Protein Orai 1 or Transmembrane Protein 142A or ORAI1) - Drugs in Development, 2021 Summary Cal...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Complement Factor B (Glycine Rich Beta Glycoprotein or C3/C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) - Drugs in Development, 2021
Complement Factor B (Glycine Rich Beta Glycoprotein or C3/C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) - Drugs in Development, ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Nodal Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021
Nodal Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021 Summary Nodal Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Develo...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 |